Europe
The Emprint™ ablation system enables a minimally invasive procedure with few side effects1, fast recovery time2,3 high accuracy4, and predictable margins.5
With the Emprint™ HP ablation system, you get consistent, predictable ablation zones - helping to eradicate a non-resectable liver tumour but preserve healthy liver tissue.5,6,7
1. Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg. 2006 Mar;243(3):321–328.
2. Hocquelet A, Balageas P, Laurent C, et al. Radiofrequency ablation versus surgical resection for hepatocellular carcinoma within the Milan criteria: A study of 281 Western patients. Int J Hyperthermia. 2015;31(7):749–757.
3. Zhang M. Ma H, Zhang J, He L, Ye X, Li X. Comparison of microwave ablation and hepatic resection for hepatocellular carcinoma: a meta analysis. Onco Targets Ther. 2017;10:4829–4839.
4. De Cobelli F, Marra P, Ratti F, et al. Microwave ablation of liver malignancies: comparison of effects and early outcomes of percutaneous and intraoperative approaches with different liver conditions. Med Oncol. 2017;34(4):49.
5. Vogl TJ, Basten LM, Nour-Eldin A, et al. Evaluation of microwave ablation of liver malignancy with enabled constant spatial energy control to achieve a predictable spherical ablation zone. Int J Hyperthermia. 2018;34(4):492–500.
6. Ruers T, Van Coevorden F, Punt CJA, et al. Local treatment of unresectable colorectal liver metastases: Results of a randomized phase II trial. J Natl Cancer Inst. 2017;109(9):djx015.
7. Drake TM, Harrison EM. Malignant liver tumours. Surgery. 2017;35(12):707–714.
8. Takahashi H et al. Local Recurrence After Microwave Thermosphere Ablation of Malignant Liver Tumors: Results of a Surgical Series. Surgery 2018 Apr;163(4):709-713.